This mid-cap pharmaceutical stock is showing signs of a rebound after taking support on a horizontal trendline. This can trigger a potential upmove in the stock by close to 7%, making the current levels attractive to enter with a favorable risk-reward ratio.118536711After breaking out from the resistance level at Rs.
Read more on economictimes.indiatimes.com